Voyager Therapeutics
VYGR
VYGR
47 hedge funds and large institutions have $146M invested in Voyager Therapeutics in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less funds holding
Funds holding: 56 → 47 (-9)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
47
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.33M | |
| 2 | +$7.04M | |
| 3 | +$1.52M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$1.48M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$944K |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$2.8M | |
| 3 | -$1.56M | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
-$732K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$579K |